Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
The independent source for health policy research, polling, and news.
541 - 560 of 959 Results
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
As Medicare considers paying for knee replacement procedures outside the hospital, doctors debate patient choice and the potential for post-operation complications.
In a region where bears outnumber people, a small medical facility sets a modern example for rural hospitals on life support.
Kaiser Health News consumer columnist gives readers some basic information to help them weigh their Medicare options.
The Commonwealth Fund finds cost barriers and limits on care for Medicare beneficiaries consistently places the U.S. low on the list of an 11-nation ranking of how older people fare in industrialized nations.
Advocates say many poor seniors who need dialysis and cancer treatments will have few transportation options.
A consumer reporter shares what she learned when getting ready to join the federal health plan for seniors.
Older adults who hope to spend the end of their lives at home need to take key steps to make that possible.
The landmark settlement was supposed to be a victory for Medicare beneficiaries with chronic conditions and disabilities who had been denied coverage for skilled care because they didn’t meet “the improvement standard” — meaning they were unlikely to improve. But when Glenda Jimmo was denied coverage this spring for that same reason, her lawyers filed a second lawsuit.
The methodology behind KHN's analysis of the third year of the Medicare penalty program.
Jeffrey Brenner, a 2013 MacArthur Fellow and executive director of the Camden Coalition of Healthcare Providers, is betting that coordinated care for "super utilizer" patients will reduce health costs.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Among the most significant difference is that patient with their own insurance don't face the same danger of losing nursing home coverage.
Federal actuaries say the economic rebound and increasing number of people with insurance will push up spending.
A study in Health Affairs finds Medicare Part D beneficiaries were charged copays averaging 10.5 times more for Crestor and Nexium than generic drugs would have cost them.
KHN's consumer columnist Michelle Andrews explores a divorced mother's efforts to get her ex-husband to keep their sons on his plan, one senior's problems getting Medicare to cover his antibiotic infusion at home and what earnings one reader will have to count when applying for premium subsidies.
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
Urban Institute researchers examine how such a plan could work and whether it would be better to make payments when people first need care or after they have used up much of their own money instead.
Over the past few months, Massachusetts, Florida, New York, Delaware and Washington have lifted restrictions on the expensive medications, and private insurers around the country are also making the changes.
© 2026 KFF